molecule healthcare limited
molecule healthcare limited Company Information
Company Number
09376001
Website
moleculehealthcare.co.ukRegistered Address
47/49 green lane, northwood, middlesex, HA6 3AE
Industry
Wholesale of pharmaceutical goods
Telephone
442030020062
Next Accounts Due
October 2024
Group Structure
View All
Shareholders
kaushik kumar bhagvanbhai mangaroliya 33.3%
sanjaykumar babubhai zalawadiya 33.3%
View Allmolecule healthcare limited Estimated Valuation
Pomanda estimates the enterprise value of MOLECULE HEALTHCARE LIMITED at £1m based on a Turnover of £1.9m and 0.55x industry multiple (adjusted for size and gross margin).
molecule healthcare limited Estimated Valuation
Pomanda estimates the enterprise value of MOLECULE HEALTHCARE LIMITED at £433.5k based on an EBITDA of £108k and a 4.01x industry multiple (adjusted for size and gross margin).
molecule healthcare limited Estimated Valuation
Pomanda estimates the enterprise value of MOLECULE HEALTHCARE LIMITED at £1.5m based on Net Assets of £748.3k and 2.06x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Molecule Healthcare Limited Overview
Molecule Healthcare Limited is a dissolved company that was located in middlesex, HA6 3AE with a Companies House number of 09376001. It operated in the wholesale of pharmaceutical goods sector, SIC Code 46460. Founded in January 2015, it's largest shareholder was kaushik kumar bhagvanbhai mangaroliya with a 33.3% stake. The last turnover for Molecule Healthcare Limited was estimated at £1.9m.
Upgrade for unlimited company reports & a free credit check
Molecule Healthcare Limited Health Check
Pomanda's financial health check has awarded Molecule Healthcare Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 3 areas for improvement. Company Health Check FAQs
5 Strong
2 Regular
3 Weak
Size
annual sales of £1.9m, make it smaller than the average company (£27.6m)
- Molecule Healthcare Limited
£27.6m - Industry AVG
Growth
3 year (CAGR) sales growth of 10%, show it is growing at a faster rate (4.7%)
- Molecule Healthcare Limited
4.7% - Industry AVG
Production
with a gross margin of 22.8%, this company has a comparable cost of product (22.8%)
- Molecule Healthcare Limited
22.8% - Industry AVG
Profitability
an operating margin of 5.7% make it more profitable than the average company (4.4%)
- Molecule Healthcare Limited
4.4% - Industry AVG
Employees
with 6 employees, this is below the industry average (41)
6 - Molecule Healthcare Limited
41 - Industry AVG
Pay Structure
on an average salary of £61k, the company has an equivalent pay structure (£61k)
- Molecule Healthcare Limited
£61k - Industry AVG
Efficiency
resulting in sales per employee of £315.4k, this is less efficient (£639.3k)
- Molecule Healthcare Limited
£639.3k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- Molecule Healthcare Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- Molecule Healthcare Limited
- - Industry AVG
Stock Days
it holds stock equivalent to 0 days, this is less than average (61 days)
- Molecule Healthcare Limited
61 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 752 weeks, this is more cash available to meet short term requirements (13 weeks)
752 weeks - Molecule Healthcare Limited
13 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 6.9%, this is a lower level of debt than the average (54.6%)
6.9% - Molecule Healthcare Limited
54.6% - Industry AVG
MOLECULE HEALTHCARE LIMITED financials
Molecule Healthcare Limited's latest turnover from March 2022 is estimated at £1.9 million and the company has net assets of £748.3 thousand. According to their latest financial statements, Molecule Healthcare Limited has 6 employees and maintains cash reserves of £800.5 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | |
|---|---|---|---|---|---|---|---|
| Turnover | |||||||
| Other Income Or Grants | |||||||
| Cost Of Sales | |||||||
| Gross Profit | |||||||
| Admin Expenses | |||||||
| Operating Profit | |||||||
| Interest Payable | |||||||
| Interest Receivable | |||||||
| Pre-Tax Profit | |||||||
| Tax | |||||||
| Profit After Tax | |||||||
| Dividends Paid | |||||||
| Retained Profit | |||||||
| Employee Costs | |||||||
| Number Of Employees | 6 | 6 | 6 | 6 | 3 | 3 | |
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | |
|---|---|---|---|---|---|---|---|
| Tangible Assets | 2,831 | 7,787 | 8,708 | 5,885 | 7,357 | 9,196 | 11,495 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 2,831 | 7,787 | 8,708 | 5,885 | 7,357 | 9,196 | 11,495 |
| Stock & work in progress | 297 | 251,367 | 279,562 | 191,000 | 120,000 | 46,450 | 40,900 |
| Trade Debtors | 0 | 0 | 30,000 | 72,182 | 0 | 0 | 15,285 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 0 | 211,658 | 102,365 | 0 | 26,061 | 33,952 | 2,368 |
| Cash | 800,492 | 419,310 | 177,560 | 88,662 | 40,993 | 98,281 | 16,666 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 800,789 | 882,335 | 589,487 | 351,844 | 187,054 | 178,683 | 75,219 |
| total assets | 803,620 | 890,122 | 598,195 | 357,729 | 194,411 | 187,879 | 86,714 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 0 | 48,223 | 89,727 | 147,252 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 1,818 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 55,335 | 132,869 | 108,057 | 0 | 29,288 | 25,562 | 1,248 |
| total current liabilities | 55,335 | 181,092 | 197,784 | 147,252 | 29,288 | 25,562 | 3,066 |
| loans | 0 | 50,000 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 60,501 | 80,524 | 87,000 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 50,000 | 0 | 0 | 60,501 | 80,524 | 87,000 |
| total liabilities | 55,335 | 231,092 | 197,784 | 147,252 | 89,789 | 106,086 | 90,066 |
| net assets | 748,285 | 659,030 | 400,411 | 210,477 | 104,622 | 81,793 | -3,352 |
| total shareholders funds | 748,285 | 659,030 | 400,411 | 210,477 | 104,622 | 81,793 | -3,352 |
| Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Operating Profit | |||||||
| Depreciation | 708 | 1,947 | 2,177 | 1,472 | 1,839 | 2,299 | 2,874 |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | |||||||
| Stock | -251,070 | -28,195 | 88,562 | 71,000 | 73,550 | 5,550 | 40,900 |
| Debtors | -211,658 | 79,293 | 60,183 | 46,121 | -7,891 | 16,299 | 17,653 |
| Creditors | -48,223 | -41,504 | -57,525 | 147,252 | 0 | 0 | 0 |
| Accruals and Deferred Income | -77,534 | 24,812 | 108,057 | -29,288 | 3,726 | 24,314 | 1,248 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | |||||||
| Investing Activities | |||||||
| capital expenditure | |||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | |||||||
| Financing Activities | |||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | -1,818 | 1,818 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | -50,000 | 50,000 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | -60,501 | -20,023 | -6,476 | 87,000 |
| share issue | |||||||
| interest | |||||||
| cash flow from financing | |||||||
| cash and cash equivalents | |||||||
| cash | 381,182 | 241,750 | 88,898 | 47,669 | -57,288 | 81,615 | 16,666 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 381,182 | 241,750 | 88,898 | 47,669 | -57,288 | 81,615 | 16,666 |
molecule healthcare limited Credit Report and Business Information
Molecule Healthcare Limited Competitor Analysis
Perform a competitor analysis for molecule healthcare limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other undefined companies, companies in HA6 area or any other competitors across 12 key performance metrics.
molecule healthcare limited Ownership
MOLECULE HEALTHCARE LIMITED group structure
Molecule Healthcare Limited has no subsidiary companies.
Ultimate parent company
MOLECULE HEALTHCARE LIMITED
09376001
molecule healthcare limited directors
Molecule Healthcare Limited currently has 3 directors. The longest serving directors include Mr Aniruddhakumar Vora (Jan 2015) and Mr Kaushik Mangaroliya (May 2017).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Aniruddhakumar Vora | England | 42 years | Jan 2015 | - | Director |
| Mr Kaushik Mangaroliya | United Kingdom | 40 years | May 2017 | - | Director |
| Mr Sanjaykumar Zalawadiya | England | 42 years | May 2017 | - | Director |
P&L
March 2022turnover
1.9m
+7%
operating profit
107.3k
0%
gross margin
22.8%
-0.73%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2022net assets
748.3k
+0.14%
total assets
803.6k
-0.1%
cash
800.5k
+0.91%
net assets
Total assets minus all liabilities
molecule healthcare limited company details
company number
09376001
Type
Private limited with Share Capital
industry
46460 - Wholesale of pharmaceutical goods
incorporation date
January 2015
age
9
incorporated
UK
accounts
Total Exemption Full
ultimate parent company
previous names
N/A
last accounts submitted
March 2022
address
47/49 green lane, northwood, middlesex, HA6 3AE
accountant
APJ ACCOUNTANCY
auditor
-
molecule healthcare limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 1 charges/mortgages relating to molecule healthcare limited. Currently there are 0 open charges and 1 have been satisfied in the past.
molecule healthcare limited Companies House Filings - See Documents
| date | description | view/download |
|---|
